Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
Wyndham Worldwide is one of the world's largest hospitality providers. The company operates more than 7,000 hotels in 67 countries on 6 continents. It also has a network of over 150 vacation ownership resorts that services 830,000 owners in North America, the Caribbean and the South Pacific.
On Apr 29, Wyndham Worldwide reported first quarter results that beat analysts' estimates by 17.14%, or 6 cents per share. Adjusted net income rose 19% to $74 million, or 41 cents per share, compared to $62 million, or 35 cents, in the year ago period. Analysts expected 35 cents.
Revenue fell by 11%, however, to $901 million, mainly due to unfavorable foreign currency effects as the U.S. dollar strengthened in its vacation exchange and rental business. Vacation rental revenue fell 19% from the year ago quarter.
2009 Outlook Reaffirmed
Wyndham is optimistic about 2009 despite the difficult economic conditions encountered in the first quarter.
"Adjusted EPS was up 17% from last year, and the Company generated net cash from operating activities of approximately $210 million," said Stephen P. Holmes, Chairman and CEO.
"These results reflect the durability of our businesses and the resilience of our fee-for-service business models, as well as strong execution and continued cost discipline," he said.
The company reaffirmed 2009 guidance of revenue between $3.5 and $3.9 billion.
Second-quarter guidance is expected in the range of 36 to 41 cents. Full-year adjusted EPS was reaffirmed and was forecast between $1.61 and $1.85.
Consensus Estimates Rise
Given the company's confirmation of previous guidance, estimates for the second quarter moved higher by 2 cents to 38 cents, or in the middle of the company's guidance range.
For the full year, estimates jumped 8.2% to $1.72 from $1.59 per share with 6 out of 6 covering analysts raising in the last week. This puts the consensus squarely in the middle of the company's guidance range.
Value Fundamentals
Wyndham Worldwide is a Zacks #1 Rank (strong buy) stock. It has an attractive price-to-earnings ratio of 8.2. Its price-to-book is 0.97. The company has an average 5-year return on equity (ROE) of 10.80%. Additionally, the company pays a dividend with a current yield of 1.80%.
Read the full Analyst Report on WYN